GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Humedix Co Ltd (XKRX:200670) » Definitions » Research & Development

Humedix Co (XKRX:200670) Research & Development : ₩0 Mil (TTM As of Mar. 2025)


View and export this data going back to 2014. Start your Free Trial

What is Humedix Co Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Humedix Co's Research & Development for the three months ended in Mar. 2025 was ₩0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2025 was ₩0 Mil.


Humedix Co Research & Development Historical Data

The historical data trend for Humedix Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Humedix Co Research & Development Chart

Humedix Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7,678.03 8,931.75 8,857.35 10,085.68 9,207.02

Humedix Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Humedix Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Humedix Co  (XKRX:200670) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Humedix Co Research & Development Related Terms

Thank you for viewing the detailed overview of Humedix Co's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Humedix Co Business Description

Traded in Other Exchanges
N/A
Address
268 Anyang Dongan Game Metallurgy, 502 Gwanyang-dong Anyang Mega Valley, Anyang, Gyeonggi, KOR, 431-809
Humedix Co Ltd is a cosmeceutical healthcare company. It supplies Hyaluronic Acid raw material medicine of low molecule and the high molecule which are used in arthritis medicine, eyedrops and in injections for ophthalmology. Further, it is dedicated to the development of new functional materials with diverse physiological activities including vitamin derivatives and supplies a variety of functional materials. In addition, it offers various medical devices, cosmetic and health functional foods. The business activities are primarily carried out through South Korea.

Humedix Co Headlines

No Headlines